Some studies have shown that switching patients from one tumor necrosis factor (TNF)-alfa inhibitor to another may be beneficial when they have an inadequate response or an adverse event.

Piaserico, S., Cazzaniga, S., Chimenti, S., Giannetti, A., Maccarone, M., Picardo, M., Peserico, A., Naldi, L., Peris, K., Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry, <<JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY>>, 2014; 70 (2): 257-257-62.e3. [doi:10.1016/j.jaad.2013.10.019] [http://hdl.handle.net/10807/57413]

Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry

Peris, Ketty
2014

Abstract

Some studies have shown that switching patients from one tumor necrosis factor (TNF)-alfa inhibitor to another may be beneficial when they have an inadequate response or an adverse event.
2014
Inglese
Piaserico, S., Cazzaniga, S., Chimenti, S., Giannetti, A., Maccarone, M., Picardo, M., Peserico, A., Naldi, L., Peris, K., Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry, <<JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY>>, 2014; 70 (2): 257-257-62.e3. [doi:10.1016/j.jaad.2013.10.019] [http://hdl.handle.net/10807/57413]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/57413
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 56
  • ???jsp.display-item.citation.isi??? 48
social impact